Susquehanna International Group’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
61,565
-39,714
| -39% | -$936K | ﹤0.01% | 2723 |
|
|
2025
Q1 | $2.43M | Buy |
101,279
+74,460
| +278% | +$1.79M | ﹤0.01% | 2040 |
|
|
2024
Q4 | $1.13M | Buy |
26,819
+7,135
| +36% | +$302K | ﹤0.01% | 2810 |
|
|
2024
Q3 | $870K | Buy |
19,684
+8,575
| +77% | +$379K | ﹤0.01% | 2867 |
|
|
2024
Q2 | $402K | Sell |
11,109
-11,434
| -51% | -$414K | ﹤0.01% | 3811 |
|
|
2024
Q1 | $972K | Sell |
22,543
-2,525
| -10% | -$109K | ﹤0.01% | 2682 |
|
|
2023
Q4 | $386K | Buy |
25,068
+5,767
| +30% | +$88.7K | ﹤0.01% | 4212 |
|
|
2023
Q3 | $265K | Buy |
19,301
+7,621
| +65% | +$104K | ﹤0.01% | 4187 |
|
|
2023
Q2 | $187K | Sell |
11,680
-17,670
| -60% | -$284K | ﹤0.01% | 4680 |
|
|
2023
Q1 | $228K | Buy |
+29,350
| New | +$228K | ﹤0.01% | 4730 |
|